(Q35209439)

7 August 2017

title

Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays (English)

1 reference

7 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michael J Merchant

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Karen J Kirkby

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

2

J Charles G Jeynes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Anne-Catherine Wéra

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Miriam A Barry

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Masao Suzuki

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

1 January 2015

1 reference

International Journal of Radiation Biology

7 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

90-98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects.

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

In vitro evaluation of combined temozolomide and radiotherapy using X rays and high-linear energy transfer radiation for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Evaluation of poly (ADP-ribose) polymerase inhibitor ABT-888 combined with radiotherapy and temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Suberoylanilide hydroxamic acid as a radiosensitizer through modulation of RAD51 protein and inhibition of homology-directed repair in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Inhibition of histone deacetylase in cancer cells slows down replication forks, activates dormant origins, and induces DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Controlling the double helix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Gamma-H2AX-based dose estimation for whole and partial body radiation exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Visualisation of γH2AX foci caused by heavy ion particle traversal; distinction between core track versus non-track damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2014.946111

10.3109/09553002.2014.946111

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json

release_vymf2b3fzrgg5d3chnrdy5m5sy

13 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vymf2b3fzrgg5d3chnrdy5m5sy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25040548%20AND%20SRC:MED&resulttype=core&format=json